发布求助
文献互助 智能选刊 最新文献

Agents and actions. Supplements最新文献

筛选
英文 中文
The complexity of the B7-CD28/CTLA-4 costimulatory pathway. B7-CD28/CTLA-4共刺激通路的复杂性。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_6
A N Schweitzer, A H Sharpe
{"title":"The complexity of the B7-CD28/CTLA-4 costimulatory pathway.","authors":"A N Schweitzer,&nbsp;A H Sharpe","doi":"10.1007/978-3-0348-8857-8_6","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_6","url":null,"abstract":"<p><p>There have been significant recent advances in our understanding of the role of the B7-CD28/CTLA-4 costimulatory pathway in T-cell activation and self-tolerance. Recent studies have begun to clarify how signaling through this pathway can influence cytokine production. The critical role for CTLA-4 in regulating T-cell activation and autoreactivity has been demonstrated, revealing a previously unsuspected means by which costimulation is involved in the maintenance and breakdown of self-tolerance. In vivo studies indicate the therapeutic potential of manipulating this important, but complex, immunoregulatory pathway.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"33-43"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
Symposium new drugs for inflammatory, allergic and immunologic disease. 炎症、过敏和免疫疾病新药研讨会。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_7
J B Summers, R D Dyer
{"title":"Symposium new drugs for inflammatory, allergic and immunologic disease.","authors":"J B Summers,&nbsp;R D Dyer","doi":"10.1007/978-3-0348-8857-8_7","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_7","url":null,"abstract":"","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"45-7"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CD40 and its ligand in cell-mediated immunity. CD40及其配体在细胞免疫中的作用。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_4
R J Noelle
{"title":"CD40 and its ligand in cell-mediated immunity.","authors":"R J Noelle","doi":"10.1007/978-3-0348-8857-8_4","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_4","url":null,"abstract":"<p><p>CD40 and its ligand (gp39, CD40L, TBAM) is central to the control of thymus-dependent humoral immunity. However, in recent years it has become evident that CD40 signaling also is critical in the development of cell-mediated immune responses. How CD40 regulates cell-mediated immunity is discussed.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"17-22"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
ICE family proteases in inflammation and apoptosis. ICE家族蛋白酶在炎症和细胞凋亡中的作用。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_2
W W Wong
{"title":"ICE family proteases in inflammation and apoptosis.","authors":"W W Wong","doi":"10.1007/978-3-0348-8857-8_2","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_2","url":null,"abstract":"<p><p>The interleukin-1 beta converting enzyme (ICE) was first identified as a unique cysteine protease that processes the inactive precursor of the pro-inflammatory cytokine IL-1 beta to its mature active form. Subsequent revelation that a C. elegans cell death gene ced-3 bears sequence homology to ICE has led to rapid identification of at least nine other members of this gene family in humans, some of which are involved in apoptosis. Analyses of ICE-deficient mice generated by gene targeting technology reveal that this enzyme is important in maturation of several cytokines. The ICE deficient mice are resistant in several models of localized and systemic inflammation. ICE itself, however, is not required for Fas-mediated apoptosis, a physiological process for elimination of activated lymphocytes. Selective inhibitors of ICE would be novel therapeutic agents for treatment of diseases where excess inflammation contributes to pathological processes.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"5-13"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells. 炎性细胞因子在抗原特异性CD4+ t细胞的生产性活化中的作用。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_5
K A Pape, M K Jenkins
{"title":"A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.","authors":"K A Pape,&nbsp;M K Jenkins","doi":"10.1007/978-3-0348-8857-8_5","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_5","url":null,"abstract":"<p><p>The mechanisms of action of immunological adjuvants were studied using a system in which the behavior of adoptively transferred CD4+ T-cell receptor transgenic T-cells could be directly monitored following antigen administration. These studies revealed that adjuvant-induced inflammatory cytokines promote immunity by enhancing the clonal expansion, persistence and differentiation of antigen-activated CD4+ T-cells.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"23-31"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways. Ro 45-2081是一种TNF受体融合蛋白，可防止气道炎症反应。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_10
P R Gater, L M Renzetti
{"title":"Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.","authors":"P R Gater,&nbsp;L M Renzetti","doi":"10.1007/978-3-0348-8857-8_10","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_10","url":null,"abstract":"<p><p>The TNF receptor fusion protein, Ro 45-2081, inhibited allergic and non-allergic inflammatory responses in the airways. Treatment of sensitized guinea-pigs with Ro 45-2081 reduced allergen-induced influx of inflammatory cells into the lungs, abolished edema formation and inhibited hyperreactivity to substance P. Administration of Ro 45-2081 after allergen challenge reversed the influx of inflammatory cells into the lungs. Sephadex-induced neutrophil influx into the lungs of rats was also blocked by Ro 45-2081. The effects of Ro 45-2081 suggest that inhibitors of TNF may have potential as therapeutics for inflammatory diseases in the lung.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"67-71"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Immunomodulation of Crohn's disease by interleukin-10. 白细胞介素-10对克罗恩病的免疫调节作用。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_9
S K Narula, D Cutler, P Grint
{"title":"Immunomodulation of Crohn's disease by interleukin-10.","authors":"S K Narula,&nbsp;D Cutler,&nbsp;P Grint","doi":"10.1007/978-3-0348-8857-8_9","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_9","url":null,"abstract":"<p><p>Interleukin-10 is an important cytokine that is involved in regulation of pro-inflammatory cytokines and T-cell responses. Interleukin-10 has been studied extensively in various preclinical and clinical models of inflammation. The most remarkable and consistently reproducible quality of IL-10 is its ability to downregulate macrophage functions. This includes inhibiting the production of pro-inflammatory cytokines such TNF-alpha, Interleukin-1, Interleukin-6 and antigen presentation by these professional antigen presenting cells. Additionally, Interleukin-10 also has effects on various other cell types of hematopoietic origin such as B-cells, neutrophils, and most importantly T-cells. Interleukin-10 has shown efficacy in several models of autoimmune disease. The present article deals with the effect of Interleukin-10 in animal models of inflammatory bowel disease and the results of phase I clinical trials in normal human volunteers and chronic active Crohn's disease patients.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"57-65"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis. 软骨保护剂(CPA) Ro 32-3555，一种治疗类风湿关节炎的新型基质金属蛋白酶抑制剂。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_8
N D Wood, M Aitken, S Durston, S Harris, G R McClelland, S Sharp
{"title":"Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.","authors":"N D Wood,&nbsp;M Aitken,&nbsp;S Durston,&nbsp;S Harris,&nbsp;G R McClelland,&nbsp;S Sharp","doi":"10.1007/978-3-0348-8857-8_8","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_8","url":null,"abstract":"<p><p>CPA was well tolerated at all dose levels (10-150 mg) following single oral dose administration to healthy male volunteers. There was no relationship between the intensity, duration and number of adverse events reported and the dose of CPA. There was a dose-related increase in exposure as measured by AUC0-infinity and Cmax. Administration of 10 mg CPA following food resulted in a delayed tmax, and a significant decrease in Cmax but not AUC0-infinity.</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"49-55"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Targets in cytokine activation. 细胞因子活化的靶点。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_1
D A Giegel, D D Chaplin
{"title":"Targets in cytokine activation.","authors":"D A Giegel,&nbsp;D D Chaplin","doi":"10.1007/978-3-0348-8857-8_1","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_1","url":null,"abstract":"<p><p>The first morning session of the Eighth International Conference of the Inflammation Research Association was titled 'Targets in Cytokine Activation'. It encompassed four areas of research that may be considered as either current or future targets. Probably the best established target of the four is interleukin-1 beta converting enzyme (ICE) and Winnie Wong from BASF Bioresearch Corporation presented an overview of work in this field. This was followed by a newly emerging target called TACE (TNF-alpha converting enzyme) in a presentation from Douglas Cerretti of Immunex. The final two presentations covered work with chemoattractant receptors (Craig Gerard, Harvard) and mice where the inducible NO synthase gene had been deleted (John Mudgett, Merck).</p>","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular mechanisms of costimulation. 共刺激的分子机制。
Agents and actions. Supplements Pub Date : 1998-01-01 DOI: 10.1007/978-3-0348-8857-8_3
S C Gilman, R J Noelle
{"title":"Molecular mechanisms of costimulation.","authors":"S C Gilman,&nbsp;R J Noelle","doi":"10.1007/978-3-0348-8857-8_3","DOIUrl":"https://doi.org/10.1007/978-3-0348-8857-8_3","url":null,"abstract":"","PeriodicalId":7491,"journal":{"name":"Agents and actions. Supplements","volume":"49 ","pages":"15-6"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20354083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信